News | Magnetic Resonance Imaging (MRI) | July 25, 2022

Combined MRI/neuromodulation/drug delivery system could revolutionize mental health and neurological therapy 

Gwangju Institute of Science and Technology researchers improve the scanning capability of magnetic particle imaging systems used for medical imaging.

July 25, 2022 —  For any drug to be successful in treating mental health or neurological problems, the medicine has to penetrate the blood-brain barrier (BBB). The BBB is caused by tight openings in the microscopic vessels of the brain which prevent harmful substances from entering the brain, but also keep most useful drugs out. For example, only 0.01% of the anti-Alzheimer therapeutic antibodies in plasma enter the brain.  Of those few drugs that can enter the brain, many cause affect unwanted targets to cause side effects (for example, dyskinesias or weight gain). In results published in the journal Pharmaceutics (https://www.mdpi.com/1999-4923/14/7/1503), Weinberg Medical Physics (WMP) has demonstrated the ability to open the blood-brain-barrier (BBB) in mice and to safely deliver drugs using pulsed magnetic fields with tailored waveforms.  This work, performed in collaboration with Georgetown University, spurs development of a new class of noninvasive image-guided devices capable of safely treating many mental health and neurological disorders. 

Funded by the National Institute for Aging grant aimed at curing Alzheimer disease, the authors demonstrated that a new type of MRI composed of electro-permanent magnets could be used to generate tailored electromagnetic waveforms, some of which were much more effective at opening the BBB than others. As in a CT scanner, the selective electromagnetic waveforms could be applied from multiple sources to focally deliver drugs to specific regions of the brain.  The same device could also use magnetic pulses to help regrow neurons (“plasticity”), as is being done with transcranial magnetic stimulation (TMS). According to Dr. Irving Weinberg, President of WMP, “This new device would allow psychiatrists and neurologists to treat diseased or underdeveloped brain tracts without causing unwanted side effects. Potential disorders to be treated could include addiction, autism, depression, neuropathic pain, and Alzheimer and Parkinson diseases.”  

Using an office-based human-sized version of this non-invasive device, it may prove possible to cure Alzheimer’s by delivering drugs and genes to specified tracts in the brain under real-time imaging guidance. 

For more information: https://www.weinbergmedicalphysics.com/ 


Related Content

News | Magnetic Resonance Imaging (MRI)

November 28, 2023 — New research being presented this week at the annual meeting of the Radiological Society of North ...

Time November 28, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
News | RSNA

November 27, 2023 — The executive leadership teams from Canon Inc. and Cleveland Clinic gathered early on day two of the ...

Time November 27, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 27, 2023 — SyntheticMR announced that its next-generation imaging solution with isotropic resolution, SyMRI 3D ...

Time November 27, 2023
arrow
News | Radiation Dose Management

November 27, 2023 — Qaelum NV, a leading provider of innovative healthcare solutions, and Philips, a global leader in ...

Time November 27, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 27, 2023 — Black patients underwent medical imaging for cognitive impairment years later than white and ...

Time November 27, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 27, 2023 — Stronger quadriceps muscles, relative to the hamstrings, may lower the risk of total knee ...

Time November 27, 2023
arrow
News | Digital Radiography (DR)

November 26, 2023 — Konica Minolta Healthcare Americas, Inc., announced today several new solutions in digital ...

Time November 26, 2023
arrow
News | Radiology Imaging

November 23, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time November 23, 2023
arrow
News | PET-CT

November 22, 2023 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the Biograph ...

Time November 22, 2023
arrow
Subscribe Now